In vitro monitoring of cellular function during BCG immunotherapy.
作者信息
Golub S H, Roth J A, Forsythe A, Morton D L
出版信息
Bibl Haematol. 1975 Oct(43):270-3. doi: 10.1159/000399146.
PMID:786261
Abstract
摘要
相似文献
1
In vitro monitoring of cellular function during BCG immunotherapy.卡介苗免疫治疗期间细胞功能的体外监测
Bibl Haematol. 1975 Oct(43):270-3. doi: 10.1159/000399146.
2
BCG immunotherapy of a mucous membrane malignant melanoma. Report of a case.卡介苗免疫疗法治疗黏膜恶性黑色素瘤。病例报告。
Oral Surg Oral Med Oral Pathol. 1976 Jul;42(1):73-9. doi: 10.1016/0030-4220(76)90032-3.
3
Immunotherapy of melanoma with intralesional BCG.采用瘤内注射卡介苗对黑色素瘤进行免疫治疗。
Natl Cancer Inst Monogr. 1973 Dec;39:213-20.
4
Experience with BCG adjuvant immunotherapy in stage II malignant melanoma.卡介苗辅助免疫疗法治疗II期恶性黑色素瘤的经验
Dev Biol Stand. 1977;38:537-40.
5
Immunotherapy of human malignant melanoma with oil-attached BCG cell-wall skeleton.用人用卡介苗细胞壁骨架油剂进行人恶性黑色素瘤的免疫治疗。
Gan. 1975 Aug;66(4):355-63.
6
Monitoring immunotherapy with Bacillus Calmette-Guérin by antibody titer.通过抗体滴度监测卡介苗免疫疗法。
Cancer Res. 1977 Jul;37(7 Pt 1):2251-6.
7
Immunotherapy in malignant melanomaa.
Natl Cancer Inst Monogr. 1976 Nov;44:85-6.
8
In vitro assay of cell-mediated immunity in BCG therapy of malignant melanoma: a preliminary report.卡介苗治疗恶性黑色素瘤的细胞介导免疫体外测定：初步报告。
Natl Cancer Inst Monogr. 1973 Dec;39:221-4.
9
Monitoring of immunologic status of patients receiving BCG therapy for malignant disease.对接受卡介苗治疗恶性疾病患者免疫状态的监测。
Cancer. 1976 May;37(5):2183-93. doi: 10.1002/1097-0142(197605)37:5<2183::aid-cncr2820370505>3.0.co;2-l.
10
Specific cytotoxic antibody in the sera of patients with melanoma.黑色素瘤患者血清中的特异性细胞毒性抗体。
J Surg Res. 1976 Nov;21(5):301-5. doi: 10.1016/0022-4804(76)90041-x.
Zotero 插件